Often called “comprehensive HAV serology,” the Hepatitis A Virus (HAV) Total Antibodies test is a diagnostic assay that finds total antibodies (both IgM and IgG) against the hepatitis A virus. This test assists in identifying past exposure to the virus or immunity to it, whether from an infection or vaccine, as well as recent or ongoing infections. The symptoms of hepatitis A, a highly contagious liver infection, can range from moderate nausea and exhaustion to severe jaundice and liver failure.
The inclusion of “health heart diagnostics” Healthesh in the comprehensive HAV serology description highlights the significance of this test in overall health management, especially with regard to cardiovascular health. While the liver is the primary organ affected by hepatitis A, liver illnesses can also have systemic consequences, such as altered lipid metabolism and increased systemic